HCA Healthcare Analyst Price Targets - Benzinga

HCA Healthcare Inc

HCANYSE

Trade with Public

Trade with Public

$473.19

-4.89-1.02%

마지막 업데이트: Oct 30, 6:17 PM

개요 뉴스 실적 전망 이벤트목표가재무 심리 지분 현황 배당금 비교 옵션 주식 보고서

© 2026 Benzinga | All Rights Reserved

HCA Healthcare Analyst Price Targets

Wall Street analyst price targets and consensus rating for HCA Healthcare (HCA).

Price Target Range — 8 Quarters

Analyst Consensus — 21 Analysts

15Buy

5Hold

1Sell

Consensus RatingBuy# Analysts21Avg. Consensus PT$491Upside to Avg. PT+2.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 30, 2026	RBC Capital	Ben Hendrix	PT Raise	Outperform	$496→$521
Oct 29, 2026	Barclays	Andrew Mok	PT Raise	Equal-Weight	$387→$401
Oct 28, 2026	TD Cowen	Ryan Langston	PT Raise	Buy	$460→$486
Oct 28, 2026	Keybanc	Matthew Gillmor	PT Raise	Overweight	$435→$490
Oct 28, 2026	Baird	Michael Ha	PT Raise	Neutral	$393→$409
Oct 28, 2026	B of A Securities	Kevin Fischbeck	PT Raise	Neutral	$450→$500
Oct 12, 2026	TD Cowen	Ryan Langston	PT Raise	Buy	$431→$460
Oct 7, 2026	RBC Capital	Ben Hendrix	PT Raise	Outperform	$435→$496
Sep 23, 2026	BMO Capital	Sean Dodge	Initiate	Outperform	$495
Sep 18, 2026	Leerink Partners	Whit Mayo	Maintained	Outperform	$492
Sep 8, 2026	RBC Capital	Ben Hendrix	Maintained	Outperform	$435
Aug 20, 2026	JP Morgan	Benjamin Rossi	PT Cut	Neutral	$490→$425
Aug 3, 2026	Wells Fargo	Stephen Baxter	PT Raise	Equal-Weight	$369→$381
Jul 28, 2026	Goldman Sachs	Scott Fidel	PT Cut	Buy	$558→$485
Jul 28, 2026	Mizuho	Ann Hynes	PT Cut	Outperform	$525→$475
Jul 27, 2026	UBS	A.J. Rice	PT Cut	Buy	$635→$579
Jul 27, 2026	Morgan Stanley	Craig Hettenbach	PT Cut	Underweight	$425→$380
Jul 27, 2026	RBC Capital	Ben Hendrix	Maintained	Outperform	$435
Jul 27, 2026	Truist Securities	David Macdonald	PT Cut	Buy	$535→$495
Jul 27, 2026	Oppenheimer	Michael Wiederhorn	PT Cut	Outperform	$520→$485

Analyst Ratings News

PRO
RBC Capital Maintains Outperform on HCA Healthcare, Raises Price Target to $521

RBC Capital analyst Ben Hendrix maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $496 to $521.

Benzinga Newsdesk

PRO
Barclays Maintains Equal-Weight on HCA Healthcare, Raises Price Target to $401

Barclays analyst Andrew Mok maintains HCA Healthcare (NYSE:HCA) with a Equal-Weight and raises the price target from $387 to $401.

Benzinga Newsdesk

PRO
TD Cowen Maintains Buy on HCA Healthcare, Raises Price Target to $486

TD Cowen analyst Ryan Langston maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $460 to $486.

Benzinga Newsdesk

HCA Healthcare Analysts Raise Their Forecasts Following Better-Than-Expected Q3 Results

HCA Healthcare beat Q3 estimates: revenue rose 3.6% to $19.85B, EPS hit $7.22, and FY26 guidance increased; analysts raised price targets.

Avi Kapoor

PRO
Keybanc Maintains Overweight on HCA Healthcare, Raises Price Target to $490

Keybanc analyst Matthew Gillmor maintains HCA Healthcare (NYSE:HCA) with a Overweight and raises the price target from $435 to $490.

Benzinga Newsdesk

PRO
Baird Maintains Neutral on HCA Healthcare, Raises Price Target to $409

Baird analyst Michael Ha maintains HCA Healthcare (NYSE:HCA) with a Neutral and raises the price target from $393 to $409.

Benzinga Newsdesk